Aminoven® 5%, 10%, 15%

Aminoven 5%, 10%

​Standard Amino acid solutions for parenteral nutrition

Features

  • Contains a balanced pattern of non-essential and conditionally essential amino acids
  • The only standard amino acid solution containing taurine which is  conditionally essential
  • Meets the requirements for essential and branched chain amino acids
  • Provides high biological value of 136 based on “Potato-egg  principle”
  • Contains different concentrations with different osmolarity to allow both peripheral and central administration

Benefits

  • Amino acid composition based upon established solutions with proved nutritional efficacy and excellent tolerance and supports better protein synthesis
  • Taurine  is conditionally essential amino acid in critical illness, trauma , sepsis, cancer, radiation and chemotherapy
  • Taurine also has immune-modulatory effects and may alleviate cholestasis in post-operative patients

Indications

For supply of amino acids as part of a parenteral nutrition regimen. Amino acid solutions should be administered generally in combination with adequate amount of energy supplements.

Packaging / Dosage

Aminoven 5%, 500 ml glass bottle , 16-20 ml/kg body wt  (equivalent to 0.8-1.0 g AA/kg body wt)

Aminoven 10% , 500 ml glass bottle, 10-20 ml/kg body wt (equivalent to 1.0-2.0 g AA/kg body wt.)

Product Information

Characteristics

AA

EAA

NEAA

BCAA

Total Nitrogen (g /L/pack)

Total Kcals

Osmolarity (mosmol/L)

Infusion Rate

Max.Dosage (ml/kg/day)

Shelf life (months)

Route of Adm

Aminoven 5%

25g

41%

59%

18.60%

4.05

100K

495

34 drops/min

20

24

peripheral

Aminoven 10%

50g

41%

59%

18.60%

8.1

200K

990

17 drops/min

20

24

peripheral/central

Reference

1. Stapleton PP, Chrles RP, Redmond HP, Bouchier-Hayes DJ: Taurine and human nutrition. Clin Nutr 16 (1997) 103-108

2. Desai Tk, et al, Taurine deficiency after intensive chemotherapy and/or radiation. Am J Clin Nuti 1992;55:708-711

3. Paauw JD, Davis AT. Taurine concentations in srum of critically injured patients and age and sex-matched healthy control subjects. Am Clin Nutr 1990;52:657-660

4. Chiarla C et al, The relationship between aurine and other amino acid levels in human sepsis J Nutr 2000;130:2222-2227

5. Geggel HS, Amend ME, Heckenlively JR, Martin DE, Kopple JD: Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 312 (1985) 142-146

6. Kopple JD, Vinton NE,Laidlaw SA, Ament ME: Effect of intravenous taurine supplementation on plasma, blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition. Am J Clin Nutr 52 (1990) 846-853

7. Wang WY, Liaw KY. Effect of taurine supplemented diet on conugated bile acids in biliary surgical patients JPEN 1991;15:294-297

8. Redmont HP et al. Immunonutrition: The role of taurine. Nutr 1998;14:599-604

9. Cooper A et al. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition J Ped Surg 1984;19:462-466